Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

Netanyahu did, then nodded and grinned. It was a remarkable moment. When Hamas carried out the worst-ever attack in Israel’s history on October 7, 2023, killing 1,200 civilians and soldiers and ...

With a little creativity, many common household items can be transformed into something else that's entirely different and ...

Warren Buffett's final letter to shareholders: Read in full Bloccelerate VC founder and CEO Kate Laurence joins ‘Mornings with Maria’ to break down digital asset growth, key takeaways from the BCVC ...